Chemokines at mucosal barriers and their impact on HIV infection

Cytokine and Growth Factor Reviews

Volumn 23, Issue 4-5, 2012, Pages 233-243

  Rancez, Magali ^a,b,c   Couëdel Courteille, Anne ^a,b,c   Cheynier, Rémi ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Chemokine; HIV; Rectal mucosa; SIV; Vaginal mucosa

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL14 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PROGESTERONE; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADAPTIVE IMMUNITY; ARTICLE; CELL HOMING; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HORMONAL REGULATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; LYMPHOID TISSUE; MENSTRUAL CYCLE; MUCOSAL IMMUNITY; NONHUMAN; PERMEABILITY BARRIER; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECTUM MUCOSA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; UTERINE CERVIX MUCOSA; VAGINA MUCOSA; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS RESISTANCE; VIRUS TRANSMISSION;

CHEMOKINES; ENDOMETRIUM; FEMALE; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; LYMPHOID TISSUE;

BACTERIA (MICROORGANISMS); SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84864912761     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.05.010     Document Type: Article

References (166)

1. Raman D., Sobolik-Delmaire T., Richmond A. Chemokines in health and disease. Experimental Cell Research 2011, 317:575-589.
2. Schall T.J., Proudfoot A.E. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nature Reviews Immunology 2011, 11:355-363.
3. Kelner G.S., Kennedy J., Bacon K.B., Kleyensteuber S., Largaespada D.A., Jenkins N.A., et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994, 266:1395-1399.
4. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
5. Allen S.J., Crown S.E., Handel T.M. Chemokine: receptor structure, interactions, and antagonism. Annual Review of Immunology 2007, 25:787-820.
6. Neel N.F., Schutyser E., Sai J., Fan G.H., Richmond A. Chemokine receptor internalization and intracellular trafficking. Cytokine & Growth Factor Reviews 2005, 16:637-658.
7. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. New England Journal of Medicine 1998, 338:436-445.
8. Miller L., Patton D.L., Meier A., Thwin S.S., Hooton T.M., Eschenbach D.A. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstetrics and Gynecology 2000, 96:431-439.
9. Coombs R.W., Reichelderfer P.S., Landay A.L. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003, 17:455-480.
10. Quayle A.J. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. Journal of Reproductive Immunology 2002, 57:61-79.
11. Wira C.R., Fahey J.V., Sentman C.L., Pioli P.A., Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunological Reviews 2005, 206:306-335.
12. Barclay C.G., Brennand J.E., Kelly R.W., Calder A.A. Interleukin-8 production by the human cervix. American Journal of Obstetrics and Gynecology 1993, 169:625-632.
13. Critchley H.O., Kelly R.W., Kooy J. Perivascular location of a chemokine interleukin-8 in human endometrium: a preliminary report. Human Reproduction 1994, 9:1406-1409.
14. Jones R.L., Kelly R.W., Critchley H.O. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Human Reproduction 1997, 12:1300-1306.
15. Takemura M., Itoh H., Sagawa N., Yura S., Korita D., Kakui K., et al. Cyclic mechanical stretch augments both interleukin-8 and monocyte chemotactic protein-3 production in the cultured human uterine cervical fibroblast cells. Molecular Human Reproduction 2004, 10:573-580.
16. Sugano T., Narahara H., Nasu K., Arima K., Fujisawa K., Miyakawa I. Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts. Molecular Human Reproduction 2001, 7:475-481.
17. Fahey J.V., Schaefer T.M., Channon J.Y., Wira C.R. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Human Reproduction 2005, 20:1439-1446.
18. Kitaya K., Yasuo T. Aberrant expression of selectin E, CXCL1, and CXCL13 in chronic endometritis. Modern Pathology 2010, 23:1136-1146.
19. Sentman C.L., Meadows S.K., Wira C.R., Eriksson M. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. Journal of Immunology 2004, 173:6760-6766.
20. Kitaya K., Nakayama T., Daikoku N., Fushiki S., Honjo H. Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium. Journal of Clinical Endocrinology & Metabolism 2004, 89:2470-2476.
21. Dominguez F., Martinez S., Quinonero A., Loro F., Horcajadas J.A., Pellicer A., et al. CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines. Molecular Human Reproduction 2008, 14:423-430.
22. Oral E., Seli E., Bahtiyar M.O., Olive D.L., Arici A. Growth-regulated alpha expression in the peritoneal environment with endometriosis. Obstetrics and Gynecology 1996, 88:1050-1056.
23. Nasu K., Fujisawa K., Arima K., Kai K., Sugano T., Miyakawa I. Expression and regulation of growth-regulated oncogene alpha in human endometrial stromal cells. Molecular Human Reproduction 2001, 7:741-746.
24. Nasu K., Arima K., Kai K., Fujisawa K., Nishida M., Miyakawa I. Expression of epithelial neutrophil-activating peptide 78 in cultured human endometrial stromal cells. Molecular Human Reproduction 2001, 7:453-458.
25. Yasuo T., Kitaya K. Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells. Fertility and Sterility 2009, 92:709-721.
26. Carlsen H.S., Baekkevold E.S., Johansen F.E., Haraldsen G., Brandtzaeg P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 2002, 51:364-371.
27. Okada T., Ngo V.N., Ekland E.H., Forster R., Lipp M., Littman D.R., et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. Journal of Experimental Medicine 2002, 196:65-75.
28. Wira C.R., Ghosh M., Smith J.M., Shen L., Connor R.I., Sundstrom P., et al. Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunology 2011, 4:335-342.
29. Kayisli U.A., Mahutte N.G., Arici A. Uterine chemokines in reproductive physiology and pathology. American Journal of Reproductive Immunology 2002, 47:213-221.
30. Akoum A., Lemay A., McColl S., Turcot-Lemay L., Maheux R. Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertility and Sterility 1996, 66:17-23.
31. Hornung D., Dohrn K., Sotlar K., Greb R.R., Wallwiener D., Kiesel L., et al. Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. Journal of Clinical Endocrinology & Metabolism 2000, 85:2604-2608.
32. Hornung D., Ryan I.P., Chao V.A., Vigne J.L., Schriock E.D., Taylor R.N. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. Journal of Clinical Endocrinology & Metabolism 1997, 82:1621-1628.
33. Altman G.B., Gown A.M., Luchtel D.L., Baker C. RANTES production by cultured primate endometrial epithelial cells. American Journal of Reproductive Immunology 1999, 42:168-174.
34. Fichorova R.N., Anderson D.J. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biology of Reproduction 1999, 60:508-514.
35. Kitaya K., Nakayama T., Okubo T., Kuroboshi H., Fushiki S., Honjo H. Expression of macrophage inflammatory protein-1beta in human endometrium: its role in endometrial recruitment of natural killer cells. Journal of Clinical Endocrinology & Metabolism 2003, 88:1809-1814.
36. Akiyama M., Okabe H., Takakura K., Fujiyama Y., Noda Y. Expression of macrophage inflammatory protein-1alpha (MIP-1alpha) in human endometrium throughout the menstrual cycle. British Journal of Obstetrics and Gynaecology 1999, 106:725-730.
37. Cha H.R., Ko H.J., Kim E.D., Chang S.Y., Seo S.U., Cuburu N., et al. Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+IgA plasma cells following mucosal vaccination via estrogen control. Journal of Immunology 2011, 187:3044-3052.
38. Nakayama T., Kitaya K., Okubo T., Kuroboshi H., Daikoku N., Fushiki S., et al. Fluctuation of 6Ckine expression in human endometrium during the menstrual cycle. Fertility and Sterility 2003, 80:1461-1465.
39. Daikoku N., Kitaya K., Nakayama T., Fushiki S., Honjo H. Expression of macrophage inflammatory protein-3beta in human endometrium throughout the menstrual cycle. Fertility and Sterility 2004, 81(Suppl 1):876-881.
40. Cremel M., Berlier W., Hamzeh H., Cognasse F., Lawrence P., Genin C., et al. Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. Journal of Leukocyte Biology 2005, 78:158-166.
41. Ghosh M., Shen Z., Schaefer T.M., Fahey J.V., Gupta P., Wira C.R. CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. American Journal of Reproductive Immunology 2009, 62:60-71.
42. Crane-Godreau M.A., Wira C.R. Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture. Infection and Immunity 2005, 73:4231-4237.
43. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Journal of Experimental Medicine 1998, 188:373-386.
44. Cook D.N., Prosser D.M., Forster R., Zhang J., Kuklin N.A., Abbondanzo S.J., et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000, 12:495-503.
45. Yeaman G.R., Collins J.E., Fanger M.W., Wira C.R., Lydyard P.M. CD8+T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 2001, 102:434-440.
46. Marchesi F., Martin A.P., Thirunarayanan N., Devany E., Mayer L., Grisotto M.G., et al. CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunology 2009, 2:486-494.
47. Lajoie J., Poudrier J., Massinga Loembe M., Guedou F., Leblond F., Labbe A.C., et al. Chemokine expression patterns in the systemic and genital tract compartments are associated with HIV-1 infection in women from Benin. Journal of Clinical Immunology 2010, 30:90-98.
48. Arici A., Seli E., Senturk L.M., Gutierrez L.S., Oral E., Taylor H.S. Interleukin-8 in the human endometrium. Journal of Clinical Endocrinology & Metabolism 1998, 83:1783-1787.
49. Arici A., Seli E., Zeyneloglu H.B., Senturk L.M., Oral E., Olive D.L. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. Journal of Clinical Endocrinology & Metabolism 1998, 83:1201-1205.
50. Critchley H.O., Kelly R.W., Brenner R.M., Baird D.T. Antiprogestins as a model for progesterone withdrawal. Steroids 2003, 68:1061-1068.
51. Glace L., Grygielko E.T., Boyle R., Wang Q., Laping N.J., Sulpizio A.C., et al. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues. Steroids 2009, 74:1015-1024.
52. Yeaman G.R., Guyre P.M., Fanger M.W., Collins J.E., White H.D., Rathbun W., et al. Unique CD8+T cell-rich lymphoid aggregates in human uterine endometrium. Journal of Leukocyte Biology 1997, 61:427-435.
53. Jolicoeur C., Boutouil M., Drouin R., Paradis I., Lemay A., Akoum A. Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis. American Journal of Pathology 1998, 152:125-133.
54. D'Anna R., Le Buanec H., Alessandri G., Caruso A., Burny A., Gallo R., et al. Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein. Journal of the National Cancer Institute 2001, 93:1843-1851.
55. Simhan H.N., Anderson B.L., Krohn M.A., Heine R.P., Martinez de Tejada B., Landers D.V., et al. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. American Journal of Obstetrics and Gynecology 2007, 196(59):e1-e5.
56. Fichorova R.N., Desai P.J., Gibson F.C., Genco C.A. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infection and Immunity 2001, 69:5840-5848.
57. McGowin C.L., Popov V.L., Pyles R.B. Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiology 2009, 9:139.
58. Ramsey K.H., Schneider H., Cross A.S., Boslego J.W., Hoover D.L., Staley T.L., et al. Inflammatory cytokines produced in response to experimental human gonorrhea. Journal of Infectious Diseases 1995, 172:186-191.
59. Fichorova R.N., Trifonova R.T., Gilbert R.O., Costello C.E., Hayes G.R., Lucas J.J., et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infection and Immunity 2006, 74:5773-5779.
60. Maxion H.K., Kelly K.A. Chemokine expression patterns differ within anatomically distinct regions of the genital tract during Chlamydia trachomatis infection. Infection and Immunity 2002, 70:1538-1546.
61. Rabin R.L., Park M.K., Liao F., Swofford R., Stephany D., Farber J.M. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. Journal of Immunology 1999, 162:3840-3850.
62. Sharkey D.J., Macpherson A.M., Tremellen K.P., Robertson S.A. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Molecular Human Reproduction 2007, 13:491-501.
63. Eckmann L., Kagnoff M.F., Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infection and Immunity 1993, 61:4569-4574.
64. Jung H.C., Eckmann L., Yang S.K., Panja A., Fierer J., Morzycka-Wroblewska E., et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. Journal of Clinical Investigation 1995, 95:55-65.
65. Butcher E.C., Williams M., Youngman K., Rott L., Briskin M. Lymphocyte trafficking and regional immunity. Advances in Immunology 1999, 72:209-253.
66. Zabel B.A., Agace W.W., Campbell J.J., Heath H.M., Parent D., Roberts A.I., et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. Journal of Experimental Medicine 1999, 190:1241-1256.
67. Papadakis K.A., Prehn J., Nelson V., Cheng L., Binder S.W., Ponath P.D., et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. Journal of Immunology 2000, 165:5069-5076.
68. Kunkel E.J., Campbell J.J., Haraldsen G., Pan J., Boisvert J., Roberts A.I., et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. Journal of Experimental Medicine 2000, 192:761-768.
69. Wurbel M.A., Philippe J.M., Nguyen C., Victorero G., Freeman T., Wooding P., et al. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. European Journal of Immunology 2000, 30:262-271.
70. Brandtzaeg P., Farstad I.N., Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunology Today 1999, 20:267-277.
71. Wang W., Soto H., Oldham E.R., Buchanan M.E., Homey B., Catron D., et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). Journal of Biological Chemistry 2000, 275:22313-22323.
72. Pan J., Kunkel E.J., Gosslar U., Lazarus N., Langdon P., Broadwell K., et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. Journal of Immunology 2000, 165:2943-2949.
73. Brandtzaeg P., Johansen F.E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunological Reviews 2005, 206:32-63.
74. John A.E., Thomas M.S., Berlin A.A., Lukacs N.W. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation. American Journal of Pathology 2005, 166:345-353.
75. Jarmin D.I., Rits M., Bota D., Gerard N.P., Graham G.J., Clark-Lewis I., et al. Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. Journal of Immunology 2000, 164:3460-3464.
76. Hieshima K., Ohtani H., Shibano M., Izawa D., Nakayama T., Kawasaki Y., et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. Journal of Immunology 2003, 170:1452-1461.
77. Warnock R.A., Campbell J.J., Dorf M.E., Matsuzawa A., McEvoy L.M., Butcher E.C. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. Journal of Experimental Medicine 2000, 191:77-88.
78. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. New England Journal of Medicine 2000, 343:1020-1034.
79. Carlsen H.S., Haraldsen G., Brandtzaeg P., Baekkevold E.S. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005, 106:444-446.
80. Baekkevold E.S., Yamanaka T., Palframan R.T., Carlsen H.S., Reinholt F.P., von Andrian U.H., et al. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. Journal of Experimental Medicine 2001, 193:1105-1112.
81. Ngo V.N., Tang H.L., Cyster J.G. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. Journal of Experimental Medicine 1998, 188:181-191.
82. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. European Journal of Immunology 1998, 28:2760-2769.
83. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. European Journal of Immunology 1999, 29:1617-1625.
84. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391:799-803.
85. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M., et al. helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. Journal of Experimental Medicine 2000, 192:1545-1552.
86. Pabst O., Ohl L., Wendland M., Wurbel M.A., Kremmer E., Malissen B., et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. Journal of Experimental Medicine 2004, 199:411-416.
87. Bowman E.P., Kuklin N.A., Youngman K.R., Lazarus N.H., Kunkel E.J., Pan J., et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. Journal of Experimental Medicine 2002, 195:269-275.
88. Agace W.W., Amara A., Roberts A.I., Pablos J.L., Thelen S., Uguccioni M., et al. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Current Biology 2000, 10:325-328.
89. Kunkel E.J., Campbell D.J., Butcher E.C. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003, 10:313-323.
90. Izadpanah A., Dwinell M.B., Eckmann L., Varki N.M., Kagnoff M.F. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. American Journal of Physiology: Gastrointestinal and Liver Physiology 2001, 280:G710-G719.
91. Beq S., Rozlan S., Gautier D., Parker R., Mersseman V., Schilte C., et al. Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood 2009, 114:816-825.
92. Rumbo M., Sierro F., Debard N., Kraehenbuhl J.P., Finke D. Lymphotoxin beta receptor signaling induces the chemokine CCL20 in intestinal epithelium. Gastroenterology 2004, 127:213-223.
93. Dwinell M.B., Lugering N., Eckmann L., Kagnoff M.F. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 2001, 120:49-59.
94. Uguccioni M., Gionchetti P., Robbiani D.F., Rizzello F., Peruzzo S., Campieri M., et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. American Journal of Pathology 1999, 155:331-336.
95. Mazzucchelli L., Hauser C., Zgraggen K., Wagner H.E., Hess M.W., Laissue J.A., et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. Journal of Pathology 1996, 178:201-206.
96. Kunkel E.J., Boisvert J., Murphy K., Vierra M.A., Genovese M.C., Wardlaw A.J., et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. American Journal of Pathology 2002, 160:347-355.
97. Agace W.W., Roberts A.I., Wu L., Greineder C., Ebert E.C., Parker C.M. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. European Journal of Immunology 2000, 30:819-826.
98. Sallusto F., Kremmer E., Palermo B., Hoy A., Ponath P., Qin S., et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. European Journal of Immunology 1999, 29:2037-2045.
99. Yang S.K., Eckmann L., Panja A., Kagnoff M.F. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997, 113:1214-1223.
100. Grimm M.C., Doe W.F. Chemokines in inflammatory bowel disease mucosa: expression of RANTES, macrophage inflammatory protein (MIP)-1α, MIP-1β, and γ-interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas. Inflammatory Bowel Diseases 1996, 2:88-96.
101. Hladik F., Hope T.J. HIV infection of the genital mucosa in women. Current HIV/AIDS Report 2009, 6:20-28.
102. Boily M.C., Baggaley R.F., Wang L., Masse B., White R.G., Hayes R.J., et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infectious Disease 2009, 9:118-129.
103. Vajdy M., Veazey R.S., Knight H.K., Lackner A.A., Neutra M.R. Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques. American Journal of Pathology 2000, 157:485-495.
104. Yeaman G.R., White H.D., Howell A., Prabhala R., Wira C.R. The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV. AIDS Research and Human Retroviruses 1998, 14(Suppl. 1):S57-S62.
105. Hu J., Gardner M.B., Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. Journal of Virology 2000, 74:6087-6095.
106. Miller C.J., Alexander N.J., Sutjipto S., Lackner A.A., Gettie A., Hendrickx A.G., et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. Journal of Virology 1989, 63:4277-4284.
107. Sodora D.L., Gettie A., Miller C.J., Marx P.A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Research and Human Retroviruses 1998, 14(Suppl. 1):S119-S123.
108. Sodora D.L., Lee F., Dailey P.J., Marx P.A. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Research and Human Retroviruses 1998, 14:171-181.
109. Ribeiro Dos Santos P., Rancez M., Pretet J.L., Michel-Salzat A., Messent V., Bogdanova A., et al. Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One 2011, 6:e19493.
110. Letvin N.L., Daniel M.D., Sehgal P.K., Desrosiers R.C., Hunt R.D., Waldron L.M., et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985, 230:71-73.
111. Xu H., Wang X., Morici L.A., Pahar B., Veazey R.S. Early divergent host responses in SHIVsf162P3 and SIVmac251 infected macaques correlate with control of viremia. PLoS One 2011, 6:e17965.
112. Stacey A.R., Norris P.J., Qin L., Haygreen E.A., Taylor E., Heitman J., et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. Journal of Virology 2009, 83:3719-3733.
113. Li Q., Estes J.D., Schlievert P.M., Duan L., Brosnahan A.J., Southern P.J., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
114. Miller C.J., Li Q., Abel K., Kim E.Y., Ma Z.M., Wietgrefe S., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. Journal of Virology 2005, 79:9217-9227.
115. Abel K., Rocke D.M., Chohan B., Fritts L., Miller C.J. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. Journal of Virology 2005, 79:12164-12172.
116. Grivel J.C., Elliott J., Lisco A., Biancotto A., Condack C., Shattock R.J., et al. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 2007, 21:1263-1272.
117. Quaranta M.G., Vincentini O., Felli C., Spadaro F., Silano M., Moricoli D., et al. Exogenous HIV-1 Nef upsets the IFN-gamma-induced impairment of human intestinal epithelial integrity. PLoS One 2011, 6:e23442.
118. Izmailova E., Bertley F.M., Huang Q., Makori N., Miller C.J., Young R.A., et al. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nature Medicine 2003, 9:191-197.
119. Baggaley R.F., White R.G., Boily M.C. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. International Journal of Epidemiology 2010, 39:1048-1063.
120. Leynaert B., Downs A.M., de Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. American Journal of Epidemiology 1998, 148:88-96.
121. Weiler A.M., Li Q., Duan L., Kaizu M., Weisgrau K.L., Friedrich T.C., et al. Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239. Journal of Virology 2008, 82:4154-4158.
122. Coplan P.M., Gortmaker S., Hernandez-Avila M., Spiegelman D., Uribe-Zuniga P., Mueller N.E. Human immunodeficiency virus infection in Mexico City. Rectal bleeding and anal warts as risk factors among men reporting sex with men. American Journal of Epidemiology 1996, 144:817-827.
123. Simmons G., Reeves J.D., Hibbitts S., Stine J.T., Gray P.W., Proudfoot A.E., et al. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunological Reviews 2000, 177:112-126.
124. Rottingen J.A., Cameron D.W., Garnett G.P. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?. Sexually Transmitted Diseases 2001, 28:579-597.
125. Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
126. Sorvillo F., Smith L., Kerndt P., Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerging Infectious Diseases 2001, 7:927-932.
127. Napierala Mavedzenge S., Van Der Pol B., Weiss H.A., Kwok C., Mambo F., Chipato T., et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS 2012, 26:617-624.
128. Spear G.T., St John E., Zariffard M.R. Bacterial vaginosis and human immunodeficiency virus infection. AIDS Research and Therapy 2007, 4:25.
129. Pereira L.H., Embil J.A., Haase D.A., Manley K.M. Prevalence of human immunodeficiency virus in the patient population of a sexually transmitted disease clinic. Association with syphilis and gonorrhea. Sexually Transmitted Diseases 1992, 19:115-120.
130. Freeman E.E., Weiss H.A., Glynn J.R., Cross P.L., Whitworth J.A., Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73-83.
131. Galvin S.R., Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nature Reviews Microbiology 2004, 2:33-42.
132. Kaul R., Pettengell C., Sheth P.M., Sunderji S., Biringer A., MacDonald K., et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. Journal of Reproductive Immunology 2008, 77:32-40.
133. Narimatsu R., Wolday D., Patterson B.K. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Research and Human Retroviruses 2005, 21:228-233.
134. Schroder J.M., Mrowietz U., Morita E., Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. Journal of Immunology 1987, 139:3474-3483.
135. Baggiolini M. Activation and recruitment of neutrophil leukocytes. Clinical and Experimental Immunology 1995, 101(Suppl. 1):5-6.
136. Gendelman H.E., Orenstein J.M., Baca L.M., Weiser B., Burger H., Kalter D.C., et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989, 3:475-495.
137. Carter C.A., Ehrlich L.S. Cell biology of HIV-1 infection of macrophages. Annual Review of Microbiology 2008, 62:425-443.
138. Lekkerkerker A.N., van Kooyk Y., Geijtenbeek T.B. Viral piracy: HIV-1 targets dendritic cells for transmission. Current HIV Research 2006, 4:169-176.
139. Teleshova N., Frank I., Pope M. Immunodeficiency virus exploitation of dendritic cells in the early steps of infection. Journal of Leukocyte Biology 2003, 74:683-690.
140. Wu L., KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nature Reviews Immunology 2006, 6:859-868.
141. Shen R., Richter H.E., Smith P.D. Early HIV-1 target cells in human vaginal and ectocervical mucosa. American Journal of Reproductive Immunology 2011, 65:261-267.
142. Zhang Z., Schuler T., Zupancic M., Wietgrefe S., Staskus K.A., Reimann K.A., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+T cells. Science 1999, 286:1353-1357.
143. Iqbal S.M., Ball T.B., Kimani J., Kiama P., Thottingal P., Embree J.E., et al. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. Journal of Infectious Diseases 2005, 192:728-738.
144. Behbahani H., Walther-Jallow L., Klareskog E., Baum L., French A.L., Patterson B.K., et al. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. Journal of Acquired Immune Deficiency Syndromes 2007, 45:9-19.
145. Pandrea I., Parrish N.F., Raehtz K., Gaufin T., Barbian H.J., Ma D., et al. Mucosal simian immunodeficiency virus transmission in african green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites. Journal of Virology 2012, 86:4158-4168.
146. Vishwanathan S.A., Guenthner P.C., Lin C.Y., Dobard C., Sharma S., Adams D.R., et al. High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. Journal of Acquired Immune Deficiency Syndromes 2011, 57:261-264.
147. Lavreys L., Baeten J.M., Martin H.L., Overbaugh J., Mandaliya K., Ndinya-Achola J., et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 2004, 18:695-697.
148. Gray R.H., Li X., Kigozi G., Serwadda D., Brahmbhatt H., Wabwire-Mangen F., et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005, 366:1182-1188.
149. McLaren P.J., Ball T.B., Wachihi C., Jaoko W., Kelvin D.J., Danesh A., et al. HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+T cell compartment and reduced expression of HIV-dependent host factors. Journal of Infectious Diseases 2010, 202(Suppl. 3):S339-S344.
150. Jennes W., Evertse D., Borget M.Y., Vuylsteke B., Maurice C., Nkengasong J.N., et al. Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. Clinical and Experimental Immunology 2006, 143:435-444.
151. Brice G.T., Graber N.L., Hoffman S.L., Doolan D.L. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-gamma production and IFN-gamma-secreting cells. Journal of Immunological Methods 2001, 257:55-69.
152. Lajoie J., Juno J., Burgener A., Rahman S., Mogk K., Wachihi C., et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunology 2012.
153. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. Journal of Experimental Medicine 1996, 184:963-969.
154. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
155. Lederman M.M., Penn-Nicholson A., Cho M., Mosier D. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006, 296:815-826.
156. Verani A., Lusso P. Chemokines as natural HIV antagonists. Current Molecular Medicine 2002, 2:691-702.
157. Hasselrot K., Bratt G., Duvefelt K., Hirbod T., Sandstrom E., Broliden K. HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior. AIDS 2010, 24:1569-1575.
158. Promadej-Lanier N., Hanson D.L., Srinivasan P., Luo W., Adams D.R., Guenthner P.C., et al. Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges. Journal of Acquired Immune Deficiency Syndromes 2010, 53:574-581.
159. Ghosh M., Fahey J.V., Shen Z., Lahey T., Cu-Uvin S., Wu Z., et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 2010, 5:e11366.
160. Lafferty M.K., Sun L., DeMasi L., Lu W., Garzino-Demo A. CCR6 ligands inhibit HIV by inducing APOBEC3G. Blood 2010, 115:1564-1571.
161. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Journal of Infectious Diseases 2005, 191:1403-1409.
162. Zhang Z.Q., Wietgrefe S.W., Li Q., Shore M.D., Duan L., Reilly C., et al. Roles of substrate availability and infection of resting and activated CD4+T cells in transmission and acute simian immunodeficiency virus infection. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:5640-5645.
163. Hladik F., Desbien A., Lang J., Wang L., Ding Y., Holte S., et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. Journal of Immunology 2003, 171:2671-2683.
164. Belyakov I.M., Ahlers J.D. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?. Journal of Immunology 2009, 183:6883-6892.
165. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nature Reviews Immunology 2006, 6:148-158.
166. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nature Medicine 2005, 11:S45-S53.